Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality

B Sat1, R Hazan, T Fisher

  • 1Department of Molecular Biology, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.

Journal of Bacteriology
|February 27, 2001
PubMed

Insights

Bacterial addiction modules, like E. coli mazEF, can trigger programmed cell death. Antibiotics inhibiting transcription or translation activate this cell death pathway by reducing antitoxin levels, allowing the toxin to kill the cell.

Area of Science:

  • Molecular Biology
  • Microbiology
  • Bacterial Genetics

Background:

  • Toxin-antitoxin gene pairs, or addiction modules, are found on bacterial extrachromosomal elements and chromosomes.
  • The Escherichia coli mazEF system is a chromosomal addiction module comprising a stable toxin (MazF) and a labile antitoxin (MazE).
  • These systems suggest an inherent capacity for programmed cell death in bacterial populations.

Purpose of the Study:

  • To investigate the role of the E. coli mazEF addiction module in mediating cell death.
  • To determine if common antibiotics can trigger cell death via the mazEF system.
  • To elucidate the mechanism by which antibiotics induce mazEF-mediated cell death.

Main Methods:

  • Exposure of E. coli cultures to antibiotics known to inhibit transcription and/or translation (rifampicin, chloramphenicol, spectinomycin).
  • Analysis of mazEF system activity and cell death induction in response to antibiotic treatment.
  • Monitoring of MazE antitoxin stability and MazF toxin activity under antibiotic stress.

Main Results:

  • Specific antibiotics (rifampicin, chloramphenicol, spectinomycin) were shown to trigger cell death mediated by the E. coli mazEF module.
  • These antibiotics function by inhibiting the continuous synthesis of the labile antitoxin, MazE.
  • The resulting imbalance, with reduced MazE and active MazF, leads to the execution of programmed cell death.

Conclusions:

  • The E. coli mazEF addiction module can be activated by antibiotics that disrupt protein synthesis or transcription.
  • Antibiotic-induced inhibition of antitoxin production is a key mechanism for activating stable toxin-mediated bacterial cell death.
  • These findings have significant implications for understanding the modes of action of certain antibiotic classes.

Related Concept Videos

Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...